ArticleLeukemia & lymphoma2011

Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma.

Maria Wysocka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.